CCL5 and adenocarcinoma: Similarly, CCL5 was significantly downregulated in adenocarcinomas (p = 0.035) (Figure 5B, left panel), although this difference was not statistically significant in the paired analysis (53% of adenomas had higher CCL5 expression, p = 0.082) (Figure 5B, right panel).